These studies indicate that FOXO1 is being prevented from performing a tumour suppressor role due to tumour microenvironmental factors supporting the CLL cells, similar to that noted for FOXO3 (103). Here, FOXO3 is linked to B-cell chronic lymphocytic leukemia.